Safety Consideration: JUVÉDERM® XC
JUVÉDERM® XC injectable gel is generally well tolerated. Most side effects are mild to moderate in nature and their duration is short lasting (7 days or less). The most common side effects include, but are not limited to, temporary injection site reactions such as redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration. As with all skin injection procedures, there is a risk of infection.
Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.
Allergies - If you're considering treatment with JUVÉDERM® injectable gel, your healthcare professional should ask about your medical history to determine if you are an appropriate candidate for treatment. JUVÉDERM® injectable gel for facial wrinkles and folds should not be used in patients who have:
Post-treatment Considerations - Your healthcare professional will tell you what to expect following treatment with JUVÉDERM® injectable gel. You should ask your healthcare professional when makeup may be applied after your treatment.
You should avoid the following for at least 24 hours after treatment:
Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites. If there is swelling, you may need to place an ice pack over the swollen area. Be sure to report any redness and/or visible swelling that lasts for more than a few days or any other symptoms that cause you concern to your healthcare professional and/or contact Allergan Product Support at 1-877-345-5372.
Other Considerations - In addition, you and your healthcare professional should discuss the following important treatment considerations in order to help avoid unsatisfactory results and complications when using JUVÉDERM® injectable gel:
Your healthcare professional should also warn you that the safety and effectiveness of JUVÉDERM® injectable gel for the treatment of areas other than facial lines and facial folds (such as lips) have not been established in controlled clinical studies.
Persons of Color - JUVÉDERM® is the first FDA-approved hyaluronic acid dermal filler with demonstrated safety and effectiveness in persons of color.
Other Treatments - Other treatments for dermal soft tissue augmentation include bovine-based collagen and other hyaluronic acid-based dermal fillers. Aside from these treatments, additional options for the correction of facial folds and wrinkles do exist, including facial creams, chemical peels, and laser skin surface treatments, and may be discussed with your healthcare professional.
Hyaluronic acid fillers are generally biocompatible, which means allergy skin testing is not required prior to treatment.
Allergies - If you're considering treatment with JUVÉDERM® injectable gel, your healthcare professional should ask about your medical history to determine if you are an appropriate candidate for treatment. JUVÉDERM® injectable gel for facial wrinkles and folds should not be used in patients who have:
- Severe allergies marked by a history of anaphylaxis or history or presence of multiple severe allergies
- A history of allergies to gram-positive bacterial proteins
- A history of allergies to lidocaine.
Post-treatment Considerations - Your healthcare professional will tell you what to expect following treatment with JUVÉDERM® injectable gel. You should ask your healthcare professional when makeup may be applied after your treatment.
You should avoid the following for at least 24 hours after treatment:
- Strenuous exercise
- Consumption of alcoholic beverages
- Extended exposure to sun or heat
Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites. If there is swelling, you may need to place an ice pack over the swollen area. Be sure to report any redness and/or visible swelling that lasts for more than a few days or any other symptoms that cause you concern to your healthcare professional and/or contact Allergan Product Support at 1-877-345-5372.
Other Considerations - In addition, you and your healthcare professional should discuss the following important treatment considerations in order to help avoid unsatisfactory results and complications when using JUVÉDERM® injectable gel:
- Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at the injection site. You should inform your healthcare professional before treatment if you are using these types of substances.
- If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with JUVÉDERM® injectable gel, there is a possible risk of an inflammatory reaction at the treatment site.
- JUVÉDERM® injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body's immune response, as there may be an increased risk of infection.
- The safety of JUVÉDERM® injectable gel for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been established.
- The safety of JUVÉDERM® injectable gel hyaluronic acid dermal filler in patients with a history of excessive scarring (eg, hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.
Your healthcare professional should also warn you that the safety and effectiveness of JUVÉDERM® injectable gel for the treatment of areas other than facial lines and facial folds (such as lips) have not been established in controlled clinical studies.
Persons of Color - JUVÉDERM® is the first FDA-approved hyaluronic acid dermal filler with demonstrated safety and effectiveness in persons of color.
Other Treatments - Other treatments for dermal soft tissue augmentation include bovine-based collagen and other hyaluronic acid-based dermal fillers. Aside from these treatments, additional options for the correction of facial folds and wrinkles do exist, including facial creams, chemical peels, and laser skin surface treatments, and may be discussed with your healthcare professional.
